Paul-Henri Lambert
Director/Board Member bij Hookipa Biotech AG
Profiel
Paul-Henri Lambert is currently the Director of the International Advanced Vaccinology Course at the University of Geneva.
He also holds the position of Director of the International Advanced Vaccinology Course at Fondation Mérieux.
Additionally, he serves as a Member of the Supervisory Board at Hookipa Biotech AG.
Previously, he worked as the Director at HOOKIPA Pharma, Inc. from 2011 to 2019.
Actieve functies van Paul-Henri Lambert
| Bedrijven | Functie | Begin |
|---|---|---|
Hookipa Biotech AG
 Hookipa Biotech AG Medical SpecialtiesHealth Technology Hookipa Biotech AG develops new generation prophylactic and therapeutic vaccines. The firm’s Vaxwave technology is a novel immunotherapy platform using a replication-defective viral vector for the prevention and treatment of cancer and infectious diseases. The company was founded by Lukas Flatz, Andreas Bergthaler, Rolf M. Zinkernagel and Daniel Pinschewer in July 2011 and is headquartered in Vienna, Austria. | Director/Board Member | - |
| Fondation Mérieux | Corporate Officer/Principal | 14-11-2013 |
| University of Geneva | Corporate Officer/Principal | - |
Eerdere bekende functies van Paul-Henri Lambert
| Bedrijven | Functie | Einde |
|---|---|---|
| HOOKIPA PHARMA INC. | Director/Board Member | 25-04-2019 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| HOOKIPA PHARMA INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
| Fondation Mérieux | Miscellaneous |
Hookipa Biotech AG
Hookipa Biotech AG Medical SpecialtiesHealth Technology Hookipa Biotech AG develops new generation prophylactic and therapeutic vaccines. The firm’s Vaxwave technology is a novel immunotherapy platform using a replication-defective viral vector for the prevention and treatment of cancer and infectious diseases. The company was founded by Lukas Flatz, Andreas Bergthaler, Rolf M. Zinkernagel and Daniel Pinschewer in July 2011 and is headquartered in Vienna, Austria. | Health Technology |
